133 related articles for article (PubMed ID: 10477840)
1. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection.
Wiesner RH; Batts KP; Krom RA
Liver Transpl Surg; 1999 Sep; 5(5):388-400. PubMed ID: 10477840
[TBL] [Abstract][Full Text] [Related]
2. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
3. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
4. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
[TBL] [Abstract][Full Text] [Related]
5. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
6. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
7. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlates to chronic renal allograft rejection.
Kasiske BL
Kidney Int Suppl; 1997 Dec; 63():S71-4. PubMed ID: 9407426
[TBL] [Abstract][Full Text] [Related]
9. Acute rejection and late renal transplant failure: risk factors and prognosis.
Pallardó Mateu LM; Sancho Calabuig A; Capdevila Plaza L; Franco Esteve A
Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome.
Wiesner RH; Demetris AJ; Belle SH; Seaberg EC; Lake JR; Zetterman RK; Everhart J; Detre KM
Hepatology; 1998 Sep; 28(3):638-45. PubMed ID: 9731552
[TBL] [Abstract][Full Text] [Related]
11. [Pathological examination for liver transplantation].
Nakayama J; Ota H; Katsuyama T; Nakazawa Y; Hashikura Y; Kawasaki S
Rinsho Byori; 2000 Nov; 48(11):1022-8. PubMed ID: 11132555
[TBL] [Abstract][Full Text] [Related]
12. Chronic rejection of the liver allograft.
Lowes JR; Hubscher SG; Neuberger JM
Gastroenterol Clin North Am; 1993 Jun; 22(2):401-20. PubMed ID: 8389736
[TBL] [Abstract][Full Text] [Related]
13. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors.
Oertel M; Berr F; Schröder S; Schwarz R; Tannapfel A; Wenzke M; Lamesch P; Hauss J; Kohlhaw K
Liver Transpl; 2000 Nov; 6(6):728-33. PubMed ID: 11084059
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic allograft rejection. Diagnostic and therapeutic aspects].
Calmus Y; Conti F; Dousset B; Houssin D
Therapie; 1992; 47(4):265-72. PubMed ID: 1494785
[TBL] [Abstract][Full Text] [Related]
15. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P
Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
[TBL] [Abstract][Full Text] [Related]
16. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
17. Incidence, timing, and risk factors for acute and chronic rejection.
Neuberger J
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S30-6. PubMed ID: 10431015
[TBL] [Abstract][Full Text] [Related]
18. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients.
Herzog D; Soglio DB; Fournet JC; Martin S; Marleau D; Alvarez F
Liver Transpl; 2008 Jul; 14(7):946-55. PubMed ID: 18581476
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
[TBL] [Abstract][Full Text] [Related]
20. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
